Effect of Benadryl Sedation During ERCP or EUS

NCT00240123 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2015-09-18

No results posted yet for this study

Summary

The purpose of the study is to determine if adding Benadryl improves sedation for patients scheduled to undergo ERCP or EUS procedures.

Conditions

  • Gallbladder Disease
  • Gallstones
  • Pancreatitis
  • Abdominal Pain
  • Jaundice

Interventions

DRUG

Benadryl versus Placebo

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Benedict Maliakkal, MD · University of Rochester Medical Center, Digestive and Liver Disease Unit

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Completion
2007-07-31

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00240123 on ClinicalTrials.gov